全文获取类型
| 收费全文 | 126288篇 |
| 免费 | 10699篇 |
| 国内免费 | 8235篇 |
学科分类
| 医药卫生 | 145222篇 |
出版年
| 2024年 | 349篇 |
| 2023年 | 1829篇 |
| 2022年 | 4675篇 |
| 2021年 | 5876篇 |
| 2020年 | 4223篇 |
| 2019年 | 4066篇 |
| 2018年 | 4135篇 |
| 2017年 | 3692篇 |
| 2016年 | 3464篇 |
| 2015年 | 5230篇 |
| 2014年 | 6540篇 |
| 2013年 | 6096篇 |
| 2012年 | 8921篇 |
| 2011年 | 9776篇 |
| 2010年 | 5957篇 |
| 2009年 | 4744篇 |
| 2008年 | 6519篇 |
| 2007年 | 6508篇 |
| 2006年 | 6554篇 |
| 2005年 | 6494篇 |
| 2004年 | 4470篇 |
| 2003年 | 4218篇 |
| 2002年 | 3562篇 |
| 2001年 | 3225篇 |
| 2000年 | 3309篇 |
| 1999年 | 3450篇 |
| 1998年 | 2244篇 |
| 1997年 | 2170篇 |
| 1996年 | 1566篇 |
| 1995年 | 1459篇 |
| 1994年 | 1268篇 |
| 1993年 | 819篇 |
| 1992年 | 1228篇 |
| 1991年 | 1075篇 |
| 1990年 | 931篇 |
| 1989年 | 823篇 |
| 1988年 | 712篇 |
| 1987年 | 670篇 |
| 1986年 | 508篇 |
| 1985年 | 463篇 |
| 1984年 | 249篇 |
| 1983年 | 178篇 |
| 1982年 | 118篇 |
| 1981年 | 116篇 |
| 1980年 | 76篇 |
| 1979年 | 120篇 |
| 1978年 | 59篇 |
| 1976年 | 52篇 |
| 1975年 | 55篇 |
| 1974年 | 65篇 |
排序方式： 共有10000条查询结果，搜索用时 15 毫秒
1.
2.
3.
4.
T. Wu L. G. Trahair M. J. Bound C. F. Deacon M. Horowitz C. K. Rayner K. L. Jones 《Diabetic medicine》2015,32(5):595-600
5.
6.
7.
Jae Eun Choi Tyler Werbel Zhenping Wang Chia Chi Wu Tony L. Yaksh Anna Di Nardo 《Journal of dermatological science》2019,93(1):58-64
Background
Rosacea is a chronic inflammatory skin condition whose etiology has been linked to mast cells and the antimicrobial peptide cathelicidin LL-37. Individuals with refractory disease have demonstrated clinical benefit with periodic injections of onabotulinum toxin, but the mechanism of action is unknown.Objectives
To investigate the molecular mechanism by which botulinum toxin improves rosacea lesions.Methods
Primary human and murine mast cells were pretreated with onabotulinum toxin A or B or control. Mast cell degranulation was evaluated by β-hexosaminidase activity. Expression of botulinum toxin receptor Sv2 was measured by qPCR. The presence of SNAP-25 and VAMP2 was established by immunofluorescence. In vivo rosacea model was established by intradermally injecting LL-37 with or without onabotulinum toxin A pretreatment. Mast cell degranulation was assessed in vivo by histologic counts. Rosacea biomarkers were analyzed by qPCR of mouse skin sections.Results
Onabotulinum toxin A and B inhibited compound 48/80-induced degranulation of both human and murine mast cells. Expression of Sv2 was established in mouse mast cells. Onabotulinum toxin A and B increased cleaved SNAP-25 and decreased VAMP2 staining in mast cells respectively. In mice, injection of onabotulinum toxin A significantly reduced LL-37-induced skin erythema, mast cell degranulation, and mRNA expression of rosacea biomarkers.Conclusions
These findings suggest that onabotulinum toxin reduces rosacea-associated skin inflammation by directly inhibiting mast cell degranulation. Periodic applications of onabotulinum toxin may be an effective therapy for refractory rosacea and deserves further study. 相似文献8.
Zhi-Ran Shi Hua Zhang Xian-Yuan Zhang Wen-Bin Wu 《Journal of Asian natural products research》2016,18(5):443-449
Two new bisamides, aglaiamides A (1) and B (2), along with three known ones (3–5), were isolated from the leaves of Aglaia perviridis. Their structures were established on the basis of detailed spectroscopic analyses. 相似文献
9.
10.
